Saturday 17 October 2026
Export HSIC’s income statement to Excel — free account
Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
86.38
0.61
−0.70%
Follow HSIC
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
22.90 | 22.54 | 23.76 | 20.25 | 17.23 | 23.63 | 14.11 | 17.49 | 21.81 | 19.54 |
Piotroski F-Score |
5 | 6 | 5 | 6 | 8 | 7 | 8 | 6 | 6 | 6 |
P/S ratio |
0.69 | 0.69 | 0.80 | 0.86 | 0.88 | 0.94 | 0.99 | 1.00 | 0.99 | 0.85 |
Altman Z-Score |
2.66 | 2.95 | 3.02 | 4.05 | 4.08 | 3.89 | 4.22 | 3.14 | 3.15 | 4.34 |
Altman Z″-Score (non-manufacturers) |
2.63 | 3.05 | 3.42 | 4.27 | 4.21 | 4.29 | 4.27 | 3.19 | 3.43 | 3.94 |
P/FCF ratio |
15.94 | 12.53 | 27.96 | 21.40 | 17.21 | 17.32 | 17.07 | 15.32 | 18.19 | 17.27 |
Beneish M-Score |
(2.51) | (2.87) | (2.28) | (2.54) | (2.48) | (2.39) | (2.28) | (2.81) | (2.37) | (2.55) |
P/Operating CF |
23.97 | 43.01 | (308.42) | 42.64 | 39.21 | 27.23 | 33.71 | 31.98 | 36.92 | 37.37 |
Dividend Safety Score |
69 | — | — | — | — | — | — | — | — | — |
P/B ratio |
2.34 | 2.18 | 2.30 | 2.64 | 2.67 | 2.39 | 2.72 | 2.65 | 3.11 | 3.53 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 17.61 | 20.08 | 9.52 | 16.58 | 8.67 | 0.00 | 61.82 |
EV/Sales |
0.86 | 0.83 | 0.96 | 0.93 | 0.93 | 0.96 | 1.05 | 1.10 | 1.07 | 0.92 |
EV/EBITDA |
11.74 | 11.33 | 13.24 | 12.26 | 10.89 | 13.50 | 11.61 | 13.88 | 11.87 | 11.26 |
EV/Operating CF |
15.90 | 12.43 | 23.57 | 19.53 | 16.29 | 16.25 | 16.04 | 15.09 | 17.48 | 16.50 |
EV/FCF |
19.75 | 15.05 | 33.39 | 23.24 | 18.33 | 17.70 | 18.15 | 16.84 | 19.74 | 18.52 |
Quick Ratio |
0.56 | 0.57 | 0.76 | 0.70 | 0.68 | 0.81 | 0.66 | 0.38 | 0.60 | 0.57 |
Current Ratio |
1.38 | 1.42 | 1.67 | 1.79 | 1.67 | 1.66 | 1.58 | 1.30 | 1.44 | 1.44 |
Net Debt/EBITDA |
2.27 | 1.90 | 2.15 | 0.97 | 0.66 | 0.28 | 0.69 | 1.25 | 0.93 | 0.76 |
Debt/Assets |
20.89% | 18.46% | 19.74% | 12.15% | 9.69% | 8.05% | 10.25% | 11.63% | 11.76% | 11.56% |
Debt/Equity |
0.60 | 0.47 | 0.49 | 0.26 | 0.20 | 0.16 | 0.20 | 0.28 | 0.33 | 0.28 |
Asset Turnover |
1.23 | 1.22 | 1.29 | 1.48 | 1.53 | 1.36 | 1.28 | 1.15 | 1.21 | 1.74 |
Operating CF/Net income |
1.79 | 2.17 | 1.20 | 1.12 | 1.13 | 1.48 | 0.94 | 1.28 | 1.34 | 1.27 |
Capex/Depreciation |
(0.45) | (0.48) | (0.53) | (0.45) | (0.38) | (0.26) | (0.41) | (0.50) | (0.47) | (0.41) |
Interest Coverage |
4.35 | 4.74 | 7.07 | 21.34 | 31.56 | 13.05 | 14.14 | 7.90 | 13.12 | 24.19 |
| 10.04% | 9.38% | 9.92% | 13.19% | 15.68% | 10.61% | 19.37% | 16.84% | 14.45% | 17.82% | |
| 3.71% | 3.75% | 4.34% | 6.30% | 7.76% | 5.41% | 8.88% | 6.55% | 5.56% | 7.64% | |
ROIC |
6.71% | 6.70% | 6.19% | 9.29% | 11.17% | 7.98% | 10.55% | 8.39% | 11.71% | 13.70% |
Return on Tangible Assets |
21.43% | 22.79% | 18.06% | 25.06% | 33.16% | 21.83% | 45.77% | 42.17% | 24.90% | 37.37% |
Average Days of Receivables |
45.71 | 42.68 | 55.11 | 41.62 | 42.74 | 51.39 | 45.55 | 45.30 | 62.57 | 39.56 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
23.39% | 23.94% | 23.96% | 21.91% | 21.24% | 20.61% | 23.61% | 23.54% | 23.32% | 20.82% |
Intangible Assets out of Total Assets |
0.47 | 0.48 | 0.45 | 0.40 | 0.42 | 0.38 | 0.42 | 0.29 | 0.38 | 0.39 |
Share Based Compensation of Revenue |
0.30% | 0.31% | 0.32% | 0.43% | 0.63% | 0.09% | 0.45% | 0.35% | 0.41% | 0.50% |
Graham Net Nets |
(0.31) | (0.25) | (0.18) | (0.05) | (0.05) | 0.00 | (0.03) | (0.08) | (0.11) | (0.06) |
Graham Number |
48.95 | 46.86 | 48.47 | 51.59 | 54.19 | 42.19 | 51.12 | 42.87 | 32.28 | 34.93 |
Earnings Yield |
4.37% | 4.44% | 4.21% | 4.94% | 5.80% | 4.23% | 7.09% | 5.72% | 4.59% | 5.12% |
Free Cash Flow Yield |
6.28% | 7.98% | 3.58% | 4.67% | 5.81% | 5.77% | 5.86% | 6.53% | 5.50% | 5.79% |
Revenue per Share |
109.13 | 99.95 | 94.47 | 92.95 | 88.52 | 71.01 | 67.56 | 61.69 | 56.66 | 71.59 |
Operating CF per Share |
5.89 | 6.69 | 3.83 | 4.42 | 5.07 | 4.20 | 4.43 | 4.49 | 3.48 | 3.98 |
Capex per Share |
(1.15) | (1.17) | (1.13) | (0.71) | (0.56) | (0.34) | (0.52) | (0.47) | (0.40) | (0.43) |
Free Cash Flow per Share |
4.74 | 5.52 | 2.70 | 3.72 | 4.50 | 3.86 | 3.91 | 4.02 | 3.08 | 3.54 |
Cash per Share |
1.29 | 0.96 | 1.31 | 0.86 | 0.84 | 2.96 | 0.72 | 0.37 | 1.11 | 0.39 |
Shareholders Equity per Share |
32.27 | 31.79 | 32.84 | 30.10 | 29.00 | 27.96 | 24.56 | 23.20 | 18.01 | 17.33 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
32.27 | 31.79 | 32.84 | 30.10 | 29.00 | 27.96 | 24.56 | 23.20 | 18.01 | 17.33 |
Free Cash Flow |
573.00 | 700.00 | 353.00 | 506.00 | 631.00 | 550.00 | 577.87 | 613.42 | 483.11 | 572.40 |
Working Capital |
1,236.00 | 1,180.00 | 1,805.00 | 1,764.00 | 1,537.00 | 1,508.31 | 1,188.13 | 956.39 | 1,257.05 | 1,022.13 |
Capital Expenditures |
(139.00) | (148.00) | (147.00) | (96.00) | (79.00) | (49.00) | (76.22) | (71.28) | (62.40) | (70.18) |
Net Current Asset Value |
(2,852.00) | (2,204.00) | (1,796.00) | (524.00) | (574.00) | 3.27 | (294.46) | (783.52) | (953.56) | (616.81) |
EV/EBIT |
17.33 | 16.97 | 19.16 | 15.74 | 13.57 | 18.19 | 14.60 | 17.20 | 14.24 | 13.74 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
13.98 | 14.13 | 16.05 | 14.50 | 12.75 | 17.81 | 13.73 | 15.65 | 13.12 | 12.81 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.50 | 0.58 | 0.55 | 0.55 | 0.57 | 0.54 | 0.56 | 0.46 | 0.36 | 0.51 |
Cash ROIC |
8.96% | 11.59% | 5.39% | 9.62% | 12.61% | 10.93% | 12.93% | 13.37% | 12.31% | 15.71% |
Accounts Receivable Turnover |
8.42 | 7.58 | 7.47 | 8.74 | 8.62 | 7.58 | 8.27 | 7.00 | 6.40 | 9.32 |
Accounts Payable Turnover |
8.58 | 8.74 | 8.38 | 8.57 | 8.47 | 7.74 | 8.28 | 6.71 | 5.68 | 8.29 |
Inventory Turnover |
4.76 | 4.78 | 4.49 | 4.61 | 5.17 | 4.97 | 4.85 | 3.89 | 3.41 | 5.26 |
Average Days of Payables |
46.39 | 40.56 | 43.91 | 41.57 | 44.08 | 50.26 | 46.60 | 44.08 | 68.58 | 44.05 |
Days of Inventory on Hand |
80.49 | 76.31 | 78.13 | 81.27 | 77.83 | 75.59 | 75.64 | 79.40 | 115.02 | 72.86 |
Average Receivables |
1,566.50 | 1,672.50 | 1,652.50 | 1,447.00 | 1,438.39 | 1,335.52 | 1,207.51 | 1,345.79 | 1,388.47 | 1,241.98 |
Average Payables |
1,058.00 | 991.00 | 1,012.00 | 1,029.00 | 1,029.83 | 942.96 | 833.01 | 969.38 | 1,080.13 | 1,006.52 |
Average Inventory |
1,906.00 | 1,812.50 | 1,889.00 | 1,912.00 | 1,686.75 | 1,470.65 | 1,422.16 | 1,674.66 | 1,799.78 | 1,587.85 |
Average Assets |
10,716.50 | 10,395.50 | 9,590.00 | 8,544.00 | 8,126.77 | 7,461.82 | 7,825.81 | 8,182.26 | 7,312.20 | 6,632.57 |
Average Common Equity |
3,965.00 | 4,160.00 | 4,192.00 | 4,079.00 | 4,023.69 | 3,807.26 | 3,585.96 | 3,183.10 | 2,812.61 | 2,843.81 |
Columns are period end dates